As a testament to the superior performance and proven results delivered by our systems, we have more systems installed and treating patients than any other compact proton therapy manufacturer.
The MEVION S250 Series integrates our patented technology at the very forefront of proton therapy to deliver exceptional beam quality, industry-leading uptime, reduced system size and complexity, higher reliability and throughput, and lower capital and operating costs. Because of this, more NCI-Designated Cancer Centers choose Mevion than any other proton therapy system provider. The Mevion advantage is clear: optimized economics, superior system performance, and proven results.
Mevion was founded in 2004 and is privately held. Our headquarters are in Littleton, Massachusetts and we have offices in the United Kingdom, China and Japan.